[go: up one dir, main page]

ATA42190A - Gelatinekapseln mit einem gehalt an ranitidin (salz) - Google Patents

Gelatinekapseln mit einem gehalt an ranitidin (salz)

Info

Publication number
ATA42190A
ATA42190A AT0042190A AT42190A ATA42190A AT A42190 A ATA42190 A AT A42190A AT 0042190 A AT0042190 A AT 0042190A AT 42190 A AT42190 A AT 42190A AT A42190 A ATA42190 A AT A42190A
Authority
AT
Austria
Prior art keywords
salt
capsules containing
gelatine capsules
containing ranitidine
ranitidine
Prior art date
Application number
AT0042190A
Other languages
English (en)
Other versions
AT401727B (de
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Canada filed Critical Glaxo Canada
Publication of ATA42190A publication Critical patent/ATA42190A/de
Application granted granted Critical
Publication of AT401727B publication Critical patent/AT401727B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT0042190A 1989-02-23 1990-02-22 Gelatinekapseln mit einem gehalt an ranitidin (salz) AT401727B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ATA42190A true ATA42190A (de) 1996-04-15
AT401727B AT401727B (de) 1996-11-25

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0042190A AT401727B (de) 1989-02-23 1990-02-22 Gelatinekapseln mit einem gehalt an ranitidin (salz)

Country Status (26)

Country Link
US (1) US5028432A (de)
JP (1) JP2856817B2 (de)
KR (1) KR940006271B1 (de)
AT (1) AT401727B (de)
AU (1) AU629303B2 (de)
BE (1) BE1003123A3 (de)
CA (1) CA2010692C (de)
CH (1) CH680567A5 (de)
CY (1) CY1734A (de)
DE (1) DE4005650C2 (de)
DK (1) DK170209B1 (de)
FR (1) FR2643263B1 (de)
GB (2) GB8904182D0 (de)
HK (1) HK89493A (de)
HU (1) HU211930A9 (de)
IE (1) IE63179B1 (de)
IL (1) IL93490A (de)
IT (1) IT1240768B (de)
LU (1) LU87681A1 (de)
NL (1) NL193267C (de)
NZ (1) NZ232642A (de)
PH (1) PH26972A (de)
SA (1) SA90100287B1 (de)
SE (1) SE512412C2 (de)
ZA (1) ZA901348B (de)
ZW (1) ZW1790A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0548238A1 (de) * 1990-09-13 1993-06-30 Smithkline Beecham Corporation Nichtwässrige flüssige orale suspensionen
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
WO1994008576A1 (en) * 1992-10-16 1994-04-28 Glaxo Group Limited Taste-masking compositions of ranitidine
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
WO2003055468A1 (en) * 2001-12-21 2003-07-10 Shire Laboratories Inc. Oral capsule formulation with increased physical stability
WO2004069180A2 (en) * 2003-01-31 2004-08-19 Smithkline Beecham Corporation Solid dispersion compositions
WO2005016312A1 (en) 2003-08-13 2005-02-24 Nobex Corporation Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
AU2010356102B2 (en) 2010-06-23 2013-09-05 Colgate-Palmolive Company Therapeutic oral composition
CN103260466B (zh) 2010-12-20 2016-08-17 高露洁-棕榄公司 含有亲水性活性物质、疏水性结构化剂和油载体的明胶包囊的口腔护理组合物
JP2014501241A (ja) 2010-12-20 2014-01-20 コルゲート・パーモリブ・カンパニー 歯科用閉塞活性剤、疎水性粘度調整剤および油担体を含有するゼラチンカプセル化された口腔ケア組成物
SG190862A1 (en) 2010-12-20 2013-07-31 Colgate Palmolive Co Non-aqueous oral care composition containing dental occlusion actives
CA3042466A1 (en) * 2016-11-01 2018-05-11 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (de) * 1980-05-17 1981-11-25 FISONS plc Mischungen, Salze, Packungen und pharmazeutische Zusammensetzungen mit Gehalt an 5-(2-Hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carbonsäure oder einem Derivat derselben und einem H2-Rezeptoren antagonisierenden Antihistamin
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
GB2084580B (en) * 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
EP0077529B1 (de) * 1981-10-16 1985-07-17 Sanol Schwarz GmbH Arzneimittelformulierung
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
SE8302689L (sv) * 1982-05-14 1983-11-15 Richter Gedeon Vegyeszet Farmaceutiska kompositioner innehallande flera aktiva bestandsdelar
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
EP0152432B1 (de) * 1983-08-01 1989-03-01 R.P. Scherer Corporation Verfahren und erzeugnis zur verzögerten freigabe
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions

Also Published As

Publication number Publication date
HK89493A (en) 1993-09-03
CA2010692C (en) 1995-12-12
IT1240768B (it) 1993-12-17
KR900012612A (ko) 1990-09-01
IT9047659A1 (it) 1991-08-22
US5028432A (en) 1991-07-02
ZA901348B (en) 1991-03-27
KR940006271B1 (ko) 1994-07-14
NL9000428A (nl) 1990-09-17
CA2010692A1 (en) 1990-08-23
JP2856817B2 (ja) 1999-02-10
JPH03200728A (ja) 1991-09-02
NZ232642A (en) 1992-07-28
FR2643263A1 (fr) 1990-08-24
IT9047659A0 (it) 1990-02-22
PH26972A (en) 1992-12-28
DK48090D0 (da) 1990-02-22
DK170209B1 (da) 1995-06-19
SA90100287B1 (ar) 1999-08-15
GB2229094B (en) 1993-01-06
ZW1790A1 (en) 1991-10-16
SE512412C2 (sv) 2000-03-13
GB9004016D0 (en) 1990-04-18
AT401727B (de) 1996-11-25
BE1003123A3 (fr) 1991-12-03
AU5007390A (en) 1990-08-30
AU629303B2 (en) 1992-10-01
IE63179B1 (en) 1995-03-22
IE900651L (en) 1990-08-23
IL93490A0 (en) 1990-11-29
CH680567A5 (de) 1992-09-30
GB8904182D0 (en) 1989-04-05
FR2643263B1 (fr) 1994-09-16
CY1734A (en) 1994-05-06
SE9000625D0 (sv) 1990-02-22
GB2229094A (en) 1990-09-19
SE9000625L (sv) 1990-08-24
DE4005650A1 (de) 1990-09-06
NL193267C (nl) 1999-05-06
DK48090A (da) 1990-08-24
LU87681A1 (fr) 1991-10-08
NL193267B (nl) 1999-01-04
DE4005650C2 (de) 1999-03-25
IL93490A (en) 1994-07-31
HU211930A9 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
ATA42190A (de) Gelatinekapseln mit einem gehalt an ranitidin (salz)
DK68392A (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
KR880011653U (ko) 의약용 캅셀
DE69029665D1 (de) Arzneimittelbehälter enthaltende Kassette
FI883785A0 (fi) Kapsel foer farmaceutiskt verksamt inhaleringsaemne i ett laekemedel.
NO831186L (no) Fortilsetning for droevtyggere
BR8300391A (pt) Ponte de medicao
DK1790D0 (da) Laegemidler indeholdende insulinderivater
DK225588D0 (da) Farmaceutisk praeparat indeholdende et litiumsalt
FI902180A0 (fi) Kapslad elektrod.
DK500988D0 (da) Kapsel
DK109887D0 (da) Farmaceutisk praeparat indeholdende antistoffer
FR2638640B1 (fr) Solution pharmaceutique
DK140983A (da) Flaget saltpraeparat
DK163638C (da) Farmaceutisk praeparat indeholdende den antibiotiske forbindelse cl-1957a eller et farmaceutisk salt deraf
FR2618303B1 (fr) Preparation de gelatine presentant un degre bloom eleve a partir de sous-produits de volaille
FI830617A0 (fi) 1,4-dihydropyridin-derivat, deras framstaellning och dessa innehaollande farmaceutiksa produkter
DE68912947D1 (de) Ein lösliches ibopamin-salz enthaltende augenarzneizubereitung.
DK164670C (da) Pyrrolooe3,2,1-hiaaindol-derivater, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende saadanne forbindelser
DK224690D0 (da) Farmaceutisk praeparat indeholdende et fluoridsalt
DK580288A (da) Farmaceutisk praeparat indeholdende imidazol-2-thioncarboxamider
DK180883D0 (da) Fiskeemballage
NO894984L (no) Toert mikrobiocid preparat inneholdende et etylen-bis-ditiokarbamatsalt.
DE3682148D1 (de) Pharmazeutische zusammensetzung mit gehalt an dinatrium cromoglicicum und an einem mucolytikum.
FR2550514B1 (fr) Capsule inviolable

Legal Events

Date Code Title Description
ELA Expired due to lapse of time